Preclinical POC data in a mouse Psoriasis model following Topical treatment with small molecule INV-17 ROR gamma inhibitor to be presented at the 2017 EADV Annual Meeting in Geneva, Switzerland

Topical administration of INV-17 small molecule ROR gamma inhibitor clinical candidate compound following disease induction in a mouse imiquimod-induced psoriasis disease model demonstrates therapeutic efficacy.

Read Here +